Evidence map›Paper›PMID 27399077›Full record

Trial reportMedicine2016

Increased Epstein-Barr virus in breast milk occurs with subclinical mastitis and HIV shedding.

Armen Sanosyan, David G Rutagwera, Jean-Pierre Molès, Karine Bollore, Marianne Peries, Chipepo Kankasa, Mwiya Mwiya, Thorkild Tylleskär, Nicolas Nagot, Philippe Van De Perre and 2 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Viruses and Human Milk: Transmission or Protection?Advances in nutrition (Bethesda, Md.) · 2023
    Review
  5. Revisiting Koch's postulate to determine the plausibility of viral transmission by human milk.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2021
    Article
  6. Best Practices for Human Milk Collection for COVID-19 Research.Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine · 2021
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Armen SanosyanUMR 1058, INSERM, Etablissement Français du Sang, Université de Montpellier, Montpellier, France Centre for International Health, University of Bergen, Bergen, Norway Department of Paediatrics and Child health, University Teaching Hospital, School of Medicine, University of Zambia, Lusaka, Zambia CHU Montpellier, Montpellier, France.
David G Rutagwera
Jean-Pierre Molès
Karine Bollore
Marianne Peries
Chipepo Kankasa
Mwiya Mwiya
Thorkild Tylleskär
Nicolas Nagot
Philippe Van De Perre
Edouard Tuaillon
ANRS 12174 Trial Group (see composition at the Acknowledgments Section)
Établissement Français du Sang · FRHôpital Arnaud de Villeneuve · FRInserm · FRUniversity of Zambia · ZMUniversité de Montpellier · FRUniversity of Bergen · NOUniversity Teaching Hospital · ZM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epstein-Barr virus (EBV) in breast milk and subclinical mastitis (SCM) are both associated with human immunodeficiency virus (HIV) shedding and possibly with postnatal HIV transmission. The objective of this nested case-control study was to investigate the interplay between SCM and EBV replication in breast milk of HIV-infected mothers.The relationships between EBV deoxyribonucleic acid (DNA) shedding, HIV-1 ribonucleic acid (RNA) level, and SCM were explored in breast milk samples of Zambian mothers participating in the ANRS 12174 trial. Mammary gland inflammation was defined as a breast milk sodium to potassium ratio (Na/K) greater than 0.6 and further subclassified as either "possible SCM" (Na/K ratio 0.6-1.0) or SCM (Na/K ratio ≥ 1.0). Breast milk interleukin 8 (IL-8) was measured as a surrogate marker of mammary gland inflammation.EBV DNA was detected in breast milk samples from 42 out of 83 (51%) participants and was associated with HIV-1 shedding in breast milk (P = 0.006). EBV DNA levels were higher in samples with SCM and "possible SCM" compared to non-SCM breast milk samples (P = 0.06; P = 0.007). An EBV DNA level of >200 copies/mL was independently associated with SCM and "possible SCM" (OR: 2.62; 95%: 1.13-6.10). In patients with SCM, higher EBV replication in the mammary gland was associated with a lower induction of IL-8 (P = 0.013). Resistance to DNase treatment suggests that EBV DNA in lactoserum is encapsidated.SCM and decreased IL-8 responses are associated with an increased EBV shedding in breast milk which may in turn facilitate HIV replication in the mammary gland.

Indexed as

Infectious Disease Transmission, VerticalVirus SheddingAdultCD4 Lymphocyte CountDNA, ViralEnzyme-Linked Immunosorbent AssayFemaleHerpesvirus 4, HumanHIV-1HIV InfectionsHumansInfant, NewbornMastitisMilk, HumanRNA, ViralZambiaDNA, ViralRNA, Viral

Identifiers

PMID27399077
PMCPMC5058806
OpenAlexW2464802799

What Socratic holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.